Deadline: 2-Mar-22
IDRC, the Israel Science Foundation (ISF), the Azrieli Foundation and the Canadian Institutes of Health Research (CIHR) are pleased to launch the first call for proposals under the second phase of the Joint Canada-Israel Health Research Program (JCIHRP).
This first call for proposals under phase II is directed toward proposals at the intersection between non-communicable chronic diseases (NCDs) and infectious diseases, while strengthening research capacity in Canada, Israel and LMICs. Potential topics may include, but are not limited to the following:
- Use of epidemiological and clinical data to gain insight into biological mechanisms influencing the intersection of chronic and infectious diseases.
- Study of mechanisms driving the interactions between non-communicable chronic and infectious diseases.
- Biomarkers and/or predictive factors of NCDs following infections or infection severity with pre-existing NCDs.
- System biology approaches.
Objectives
Phase II of the Joint Canada-Israel Health Research Program is expected to:
- Advance research and discovery in global health and biomedical sciences;
- Encourage scientific collaboration and knowledge mobilization between Canadian, Israeli and LMIC researchers and trainees; and
- Reinforce capacity in global health and biomedical science with researchers and trainees.
Research Areas
Topics may include, but are not limited to, the following:
- Analysis of epidemiological and clinical data, including electronic health records, to define the underlying biological, socio-behavioural, and ecological factors influencing the intersection of NCDs and infectious diseases to gain insight into biological mechanisms;
- Study of mechanisms driving the interactions between NCDs and infectious diseases. This may include genetic, epigenetic, immunological, metabolic, cellular, and inflammatory mechanisms. For example, projects may include post-viral syndrome and its interactions with NCDs and/or how existing NCDsredispose individuals for poor infectious disease outcomes, using a variety of approaches;
- Systems biology approaches to gain insight into molecular mechanisms underlying the reciprocal impacts of infectious diseases and agents on NCDs;
- Identification of biomarkers and/or predictive factors of NCDs following infections or infection severity with pre-existing NCDs; and
- Translational approaches, including diagnostic tools and other techniques and solutions, aimed at disrupting and preventing NCDs caused/accelerated by infectious diseases and/or mitigating the severity of infectious disease in people with NCDs.
- Interactions between non-communicable chronic obesity-related, diabetes, kidney, gastrointestinal and liver diseases and infectious diseases using a variety of approaches, including systems biology and translational approaches, aimed at disrupting, preventing or mitigating NCDs caused by or accelerated by infectious diseases, or mitigating the severity of infectious diseases in individuals with pre-existing NCDs.
Funding Information
Phase II of JCIHRP seeks to support fundamental research at the cutting-edge of biomedical science and global health. Six grants worth up to CA$ 1.4 million each will be awarded to research teams based in Canada, Israel and low- and middle-income countries (LMICs) for a period of up to four years.
Eligibility Criteria
For an application to be eligible:
- For administrative purposes only, the Nominated Principal Applicant must be the Canadian investigator co-leading the team.
- Nominated Principal Applicant (NPA) must be an independent researcher appointed at an eligible institution.
- A maximum of one Principal Applicant must be the Israeli investigator co-leading the team.
- A maximum of one Principal Applicant must be the LMIC investigator co-leading the team.
- For the Canadian arm of the team, applications involving First Nations, Inuit, Métis and/or Urban Indigenous populations must include at least one participant who self-identifies as First Nations, Inuit, or Métis and/or who can demonstrate their experience of meaningful and culturally safe involvement with Indigenous Peoples in an Indigenous Health Research environment on the research team. At least one participant meeting this criteria must submit an “Other” attachment describing their experience working in an Indigenous Health Research environment.
- If relevant, the LMIC investigator co-leading the team is invited to reflect on how their research application could involve Indigenous populations related to their specific context.
- In your knowledge mobilization plan, as a minimum eligibility requirement, all proposals must support at least one of the following activities aimed at supporting capacity and scientific relationships:
- significant training opportunities such as scientific workshops, graduate training in low- and middle-income countries, Canada and Israel or summer schools benefiting researchers/trainees in eligible low and middle income countries; and/or
- inclusion of trainees from low and middle income countries, Canada and Israel in carrying out the research.
- Proposals must be co-led by three independent investigators, one from Canada, Israel and an eligible LMIC. Teams are required to establish a knowledge mobilization plans. This could include a range of activities that support research, training and exchange, while taking advantage of this funding opportunity to design a collaborative international research project.
For more information, visit https://www.idrc.ca/en/news/announcement-call-proposals-joint-canada-israel-health-research-program-phase-ii-2021-2022
